1 |
Chow, S. C. and Liu, J. P. (2008). Design and Analysis of Bioavailability and Bioequivalence Studies, 3rd edition, Chapman and Hall CRC.
|
2 |
Japan National Institute of Health, Division of Drugs (2006). Guideline for Bioequivalence Studies of Generic Products, Japan.
|
3 |
박상규 (2007). On sample size determination of bioequivalence trials, <한국데이터정보과학회지>, 18, 365-373.
|
4 |
박상규, 남봉헌, 정윤노, 이재영, 정규진 (2010). 생물학적 동등성 시험의 추가시험에 대한 통계적 고찰, <한국통계학회논문집>, 17, 107-115.
|
5 |
식품의약품안전청 (2007). 생물학적 동등성 시험기준(제2007-65호).
|
6 |
Canada Department of Health (1992). Guidance for Industry, Conduct and Analysis of Bioavailability and Bioequivalence Studies-Part A: Oral Dosage Formulations Used for Systemic Effects, Canada.
|